Atrasentan in Treating Patients With Prostate Cancer

Clinical trial NCT00046943 · COMPLETED

Trial details

NCT number: NCT00046943
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2002-09-01
Primary completion: 2007-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.